![Elliott Levy](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Elliott Levy
Directeur/Membre du Conseil chez
OMEA THER
Fortune : 3 907 $ au 31/03/2024
Profil
Elliott M.
Levy is the founder of Intrepid Alliance.
Current jobs include Independent Non-Executive Director at NuCana Plc since 2021, Independent Director at Editas Medicine, Inc. since 2023, Independent Director at Omega Therapeutics, Inc. since 2021, Director at Kinaset Therapeutics, Inc., Venture Partner at 5AM Venture Management LLC since 2022, Senior Advisor at The Boston Consulting Group, and Media Contact at HeartFlow, Inc. Former jobs include Chairman at Transcelerate Biopharma, Inc. from 2017 to 2019, SVP-Strategy, Operations, Research & Development at Amgen, Inc. from 2020 to 2021, Senior Vice President & Head-Specialty Development at Bristol Myers Squibb Co. from 1997 to 2014, and Member-Renal Division at The Brigham & Women's Hospital, Inc. Education includes a doctorate from Yale School of Medicine conferred in 1987 and undergraduate studies at Yale College.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
NUCANA PLC 0,05% | 18/03/2026 | 15 026 ( 0,05% ) | 3 907 $ | 31/03/2024 |
| 20/04/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
Postes actifs de Elliott Levy
| Sociétés | Poste | Début |
|---|---|---|
| OMEA THER | Directeur/Membre du Conseil | 01/03/2021 |
| NUCANA PLC | Directeur/Membre du Conseil | 01/11/2021 |
| EDITAS MEDICINE, INC. | Directeur/Membre du Conseil | 11/04/2023 |
| HEARTFLOW, INC. | Public Communications Contact | - |
5AM Venture Management LLC
 5AM Venture Management LLC Investment ManagersFinance 5AM Ventures invests in companies located in the US with an investment size ranging from $20 to $30 million. The firm targets companies operating in the fields of life sciences. It provides financing for early stage and corporate spin-out capital requirements and also makes co-investments. | Private Equity Investor | 01/01/2022 |
The Boston Consulting Group | Consultant / Advisor | - |
Kinaset Therapeutics, Inc.
 Kinaset Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops inhaled therapeutics for respiratory diseases | Directeur/Membre du Conseil | - |
Anciens postes connus de Elliott Levy
| Sociétés | Poste | Fin |
|---|---|---|
| AMGEN INC. | Directeur Technique/Scientifique/R&D | 01/05/2021 |
Transcelerate Biopharma, Inc.
 Transcelerate Biopharma, Inc. BiotechnologyHealth Technology Provides biopharmaceutical research services | Président | 01/09/2019 |
| ░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░ ░░░░░░░ ░░░░░ ░░░░░░░░░░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Formation de Elliott Levy
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
93
Relations au 1er degré
13
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 13 |
|---|---|
Amgen, Inc.
 Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Bristol Myers Squibb Co.
 Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
HeartFlow, Inc.
 HeartFlow, Inc. Packaged SoftwareTechnology Services Develops AI powered medical imaging platform that uses a patient’s coronary CT scan (CCTA) to build a personalized 3-D model of their heart and deliver a non-invasive solution for diagnosing & managing coronary artery disease | Technology Services |
The Brigham & Women's Hospital, Inc.
 The Brigham & Women's Hospital, Inc. Hospital/Nursing ManagementHealth Services Provides health care services | Health Services |
5AM Venture Management LLC
5AM Venture Management LLC Investment ManagersFinance 5AM Ventures invests in companies located in the US with an investment size ranging from $20 to $30 million. The firm targets companies operating in the fields of life sciences. It provides financing for early stage and corporate spin-out capital requirements and also makes co-investments. | Finance |
NuCana Plc
 NuCana Plc BiotechnologyHealth Technology Develops and commercializes novel anti-cancer medicines | Health Technology |
Editas Medicine, Inc.
 Editas Medicine, Inc. BiotechnologyHealth Technology Manufactures gene editing medicines | Health Technology |
Yale School of Medicine
 Yale School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Transcelerate Biopharma, Inc.
Transcelerate Biopharma, Inc. BiotechnologyHealth Technology Provides biopharmaceutical research services | Health Technology |
Yale College
 Yale College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Boston Consulting Group | |
Omega Therapeutics, Inc.
 Omega Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutics for general and rare genetic diseases, immunology, inflammation, oncology and metabolic diseases | Health Technology |
Kinaset Therapeutics, Inc.
Kinaset Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops inhaled therapeutics for respiratory diseases | Health Technology |
